Eppendorf的問題,透過圖書和論文來找解法和答案更準確安心。 我們找到下列問答集和資訊懶人包

Eppendorf的問題,我們搜遍了碩博士論文和台灣出版的書籍,推薦Fink, Bernd寫的 Femoral Revision Arthroplasty 和的 Cutaneous Drug Hypersensitivity: Clinical Features, Mechanisms, Diagnosis, and Management都 可以從中找到所需的評價。

另外網站Eppendorf | Nature也說明:The Eppendorf Award for Young European Investigators was first established in 1995. It acknowledges outstanding contributions to biomedical research in ...

這兩本書分別來自 和所出版 。

高雄醫學大學 熱帶醫學碩士學位學程 師健民所指導 Cristell Janette Duarte Cheretti的 巴拉圭家飼動物外侵襲病媒蜱之蜱媒介病原體的分子檢測 (2021),提出Eppendorf關鍵因素是什麼,來自於巴拉圭。

而第二篇論文國立清華大學 奈米工程與微系統研究所 陳致真所指導 陳致嘉的 開發紙基系統以同時使用多種抗體富集胞外體 (2020),提出因為有 胞外體、紙基裝置、紙基平台、生物性標誌的重點而找出了 Eppendorf的解答。

最後網站Eppendorf UNI-ONWARD 友和代理則補充:Eppendorf 是一家領先的生命科學公司,在全球實驗室中開發和銷售用於液體、樣品及細胞處理的儀器、耗材和服務。 ... 移液器吸頭EpTips,試管Tubes,微量滴定板MicroPlate和 ...

接下來讓我們看這些論文和書籍都說些什麼吧:

除了Eppendorf,大家也想知道這些:

Femoral Revision Arthroplasty

為了解決Eppendorf的問題,作者Fink, Bernd 這樣論述:

Prof Bernd Fink, after education and fellowships in several trauma centers and university hospitals since 2001, is Professor for Orthopaedic Surgery at the University-Hospital Hamburg-Eppendorf, Germany.Since 2004 he work as the Head of Department of Joint Replacement, General and Rheumatic Orthopae

dics of the Orthopaedic Clinic Markgröningen, Germany. He has been working in the field of hip revision arthroplasty for over 20 years and is very active as lecturer in educational courses in hip revision arthroplasty organized both by companies and societies. He is author of many papers in high ran

ked peer-reviewed journals in the topic of hip revision surgery and winner of several sientific awards. He was Vice-President, President and Past-President in the German Society for Joint Replacement. He is Reviewer for the following journals in the field of hip revision arthroplasty: Clinical Ortho

paedics and Related Research, Bone and Joint Journal, Journal of Arthroplasty, Lancet Infection Disease, Journal of Orthopaedic Research, Arthroplasty Today, Antibiotics, Archives of Orthopaedic and Trauma Surgery, BMC Musculoskeletal Diseases.

Eppendorf進入發燒排行的影片

巴拉圭家飼動物外侵襲病媒蜱之蜱媒介病原體的分子檢測

為了解決Eppendorf的問題,作者Cristell Janette Duarte Cheretti 這樣論述:

研究背景: 雖然已有許多研究報導有關南美洲國家之蜱媒介疾病,然而卻僅有極少數研究有關巴拉圭之蜱種分佈及病原體傳播。因而本研究將有貢獻於巴拉圭及南美洲之科學、醫學及獸醫界。研究目的: 我們的目的將運用蜱種形態特徵,以確認採集自巴拉圭四個省份之家飼動物外侵襲蜱種株,同時並使用巢式聚合酶鏈反應及定序分析技術,以檢測蜱隻感染立克次體菌狀況及確認其基因種。研究方法: 所有採集自家飼動物之蜱隻於2011年5至8月期間完成,並使用蜱隻移除鑷子自動物摘離後置於標示密封袋內於冰箱內保存,直至運抵實驗室後置入含75%酒精之離心管內,並使用立體解剖顯微鏡以鑑定其蜱屬及種株。每隻蜱隻於萃取核酸(DNA)前皆經超音波

震盪清洗,並針對邊蟲之16S rRNA基因進行巢式聚合酶鏈反應之檢測,檢測得之陽性樣本再續以基因定序處理。研究結果: 所有蜱隻採集自犬、貓、牛、馬及羊等31個宿主動物,共計採得來自巴拉圭四個省份之333蜱隻,蜱種鑑定顯示其中包含54.6%之微小牛蜱(Rhipicephalus microplus)、27.6%之褐黃狗蜱(Rhipicephalus sanguineus)、 14.1%之革蜱(Dermacentor nitens) 及 3.6%之五種花蜱(Amblyomma spp.)。而針對邊蟲16S rRNA基因進行邊蟲感染之分子檢測,則顯示採得蜱隻分別具有6.6% (22/333)及21.

3% (71/333) 之A. marginale 及A.centrale的陽性率,而陽性樣本之定序結果亦顯示與GenBank資料庫已知之A. marginale and A. centrale具有100%基因序列相似度。討論: 本研究顯示扇頭蜱屬(Rhipicephalus spp.)乃巴拉圭多數區域家飼動物之主要寄生蜱種,由於採集得花蜱數量較少,故而無法於本研究確認其實際盛行狀況。本研究結果證實A. marginale 及A. centrale兩種邊蟲存在於巴拉圭蜱隻,並分別具有6.6% 及21.3%之感染率。本結果亦建議有關蜱媒介邊蟲病之漠視及誤診,此狀況促使邊蟲感染成為巴拉圭公衛上被忽

略之重要動物疾病,並威脅人類健康。

Cutaneous Drug Hypersensitivity: Clinical Features, Mechanisms, Diagnosis, and Management

為了解決Eppendorf的問題,作者 這樣論述:

Andreas J. Bircher is emerited Clinical Professor, and was until June 2018 Head of the Allergy Unit, and Vice Chairman of the Department of Dermatology at the University Hospital Basel, Switzerland. He is an accredited specialist in Dermatology/Venereology and Allergology/Clinical Immunology. He was

awarded the Teaching Excellence Award of the University of Basel in 2017. From 2018 on he is Associated Professor at the Università della Svizzera Italiana in Lugano, Switzerland where he is involved in the planning and set-up of the new curriculum of the Master in Medicine, and is responsible for

the module "Immune Disorders" including Dermatology, Allergology, Immunology and Rheumatology. Dr. Bircher is a cofounding member of the European Network on Drug Allergy (ENDA), a member of the Drug Hypersensitivity Interest Group (EAACI), and a member of the leading national and international scien

tific societies in the field. His clinical and research work focuses on drug hypersensitivity, and his Habilitation thesis on drug hypersensitivity was published in 1996 by Thieme (Arzneimittelallergie und Haut). Howard Maibach is a professor in the Department of Dermatology at University of Califor

nia, San Francisco and an internationally acknowledged expert in contact and occupational dermatitis, skin exposure toxicity, allergies and skin disorders, and dermatopharmacology. Dr. Maibach has been on the editorial board of more than 30 scientific journals and is a member of 19 professional soci

eties, including the American Academy of Dermatology, San Francisco Dermatological Society, and the Internal Commission on Occupation Health.Prof. Dr. med. Annick Barbaud, MD, PhD is University professor and Head expert for Dermatology and Allergology. After studying medicine at the Necker-Enfants M

alades Hospital, Dr Barbaud joined the Nancy University Hospital. Passionate about immunology, she quickly specialized in allergology and focused her fundamental research on the subject of drug induced skin eruptions. Appointed University Professor, she heads a very active research unit whose work i

s internationally recognized. In 2016, she moved to Paris, becoming the head of the Dermatology and Allergy department of Tenon hospital in the AP-HP.Sorbonne University. This department is the most important for skin and drug allergies in Paris region. She is the secretary of the Board of the Drug

Allergy interest group of the European Academy of Allergy and Clinical Immunology, secretary of the European Network for Drug Allergy, the Co-founder and past-president of the "FISARD-Toxidermie" group and the founder of the "Dermato-allergology" group of the French Society of Dermatology. She is al

so the past President of the Groupe d’Etude et Recherche en Dermato-allergologie (GERDA). Her main topics focus is on contact dermatitis, cutaneous adverse drug reactions and standardisation of allergy work-up in drug allergy.Prof. Dr. med. Knut Brockow is Associate professor and Head of the Allergy

Unit at the Department of Dermatology and Allergology Biederstein, Technical University of Munich. After his Medical studies at the Rheinische Friedrich-Wilhelms-Universität Bonn with internships in Harare (Zimbabwe), Glarus (Switzerland) and Bonn, he passed the American state examination (ECFMG pa

rts 1 and 2). Prof. Brockow completed his specialist training at the University Dermatology Clinic Hamburg Eppendorf and the Department of Dermatology and Allergology Biederstein, Technical University of Munich. His habilitation topic was on the topic "Mast cells, mediators and mutations in mastocyt

osis". His activities include a two-year Postdoctoral Research Fellowship at the Laboratory of Allergic Diseases (Head: Dr. Dean Metcalfe), NIAID, NIH, Bethesda, MD, USA as a fellow of the John E. Fogarty International Center, Bethesda, USA. Dr. Brockow is a past president of the European Network on

Drug Allergy (ENDA), a member of the Drug Hypersensitivity Interest Group (EAACI), the chair of the drug allergy section of the German scientific Allergy society and the EAACI Exam Committee Chair. His main research fucus is on anaphylaxis, mast cell diseases and particularly drug hypersensitivity.

開發紙基系統以同時使用多種抗體富集胞外體

為了解決Eppendorf的問題,作者陳致嘉 這樣論述:

胞外體已經在生物研究領域方面獲得的極大的關注,由於胞外體擁有許多獨特的地方,像是做為細胞間傳遞訊息的橋樑,以及具有做為預防與診斷疾病的生物標誌。我們不只對於胞外體傳遞訊息的特徵感到好奇,也想透過胞外體所表現的生物特徵去判斷我們器官的健康狀態。在我們想要了解身體器官間的溝通前,我們首先必須知道如何將胞外體成功的分離出來。目前為止也已經有許多分離胞外體的方法,像是差速高速離心法(differential ultracentrifigation),是廣為被使用的分離胞外體方式,然而分離過程十分的耗時、操作的器材也相對比較笨重且昂貴,回收率也相對較低,而且在極高的轉速之下,也容易造成胞外體降解,並使

蛋白質群聚等不好的現象。因此在分離胞外體的系統上,我們選擇使用紙基裝置做為我們分離胞外體的平台。目標是希望可以打造擁有以下優點的紙基裝置: 方便、快速、低成本,以及藉由它高篩選率的特性,將我們的目標胞外體成功的從溶液中分離出來。除了做出更簡便的實驗步驟外,我們最後希望可以透過我們的紙基裝置利用不同的抗體同時分離出帶有不同表面抗原的胞外體,將整體分離的效率達到最大化。